The Treatment of Type I Open Fractures in Pediatrics
Launched by ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO · Mar 25, 2009
Trial Information
Current as of November 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the treatment of type I open fractures in children, which are injuries where the bone is broken and the skin is also damaged. Normally, these fractures require surgery to clean the wound and fix the bone. However, some doctors think that smaller open fractures might be treated safely in the emergency room without surgery, using simple methods like cleaning the wound and providing antibiotics. The goal of this study is to find out if treating these injuries without surgery can lead to similar healing results, such as infection rates and recovery time.
To participate in this trial, children aged 3 to 14 with specific types of open fractures may be eligible. Key criteria include having a small wound (less than 1 cm) and an injury from a low-energy event, like a fall from a short height. The children who join the study will be randomly assigned to either receive standard surgical treatment or emergency room care without surgery. Throughout the trial, researchers will monitor and compare how well both groups heal, looking at factors like infection rates and the need for follow-up procedures. This trial is currently recruiting participants, and it aims to provide valuable insights into how we can best treat these injuries in young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • open fracture amenable to treatment by closed reduction
- • low energy mechanism of injury (e.g., falls from less than 10 feet, bicycle accidents)
- • wound less than 1cm in length and the bone not visualized through the skin
- Exclusion Criteria:
- • open fracture not amenable to treatment by closed reduction
- • open fracture that would typically require operative reduction and fixation
- • high energy mechanism of injury (e.g., struck by vehicle, motor vehicle accidents, fall from height greater than 10 feet)
- • wound greater than 1cm in length
- • gross contamination of wound
- • open fractures involving hands or feet (the current standard of care to treat open injuries involving hands or feet is only emergency room management)
About Ann & Robert H Lurie Children's Hospital Of Chicago
Ann & Robert H. Lurie Children's Hospital of Chicago is a leading pediatric healthcare institution dedicated to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating novel therapies and treatments tailored for children. With a commitment to evidence-based practices and a multidisciplinary approach, Lurie Children's collaborates with various stakeholders to enhance pediatric care and improve health outcomes for children locally and globally. Through its robust research programs, the hospital aims to transform pediatric medicine and address the unique challenges faced by young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Joseph (Jay) A Janicki, MD, MS
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials